Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Rein Therapeutics Inc. (RNTX) had Operating Cash Flow per Share of $-0.76 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-49.87M |
|
-- |
|
-- |
|
$50.63M |
|
$-50.63M |
|
$0.05M |
|
$-50.58M |
|
$-50.58M |
|
$-49.87M |
|
$-49.87M |
|
$-49.87M |
|
$-49.87M |
|
$-50.63M |
|
$-21.93M |
|
25.45M |
|
25.45M |
|
$-1.96 |
|
$-1.96 |
|
| Balance Sheet Financials | |
$4.33M |
|
-- |
|
$19.83M |
|
$24.16M |
|
$6.18M |
|
-- |
|
$46.06M |
|
$52.24M |
|
$-28.09M |
|
$-47.92M |
|
$-28.09M |
|
27.55M |
|
| Cash Flow Statement Financials | |
$-19.36M |
|
-- |
|
$9.76M |
|
$12.87M |
|
$3.21M |
|
$-9.65M |
|
$2.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.70 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-19.36M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
177.56% |
|
104.08% |
|
-206.44% |
|
177.56% |
|
$-1.02 |
|
$-0.76 |
|
|
Operating Cash Flow per Share |
$-0.76 |